Marshall Wace, LLP Enzo Biochem Inc Transaction History

Marshall Wace, LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	BUY	$2.86 - $3.61 $82,679 - $104,361	28,909 New	28,909 $92,000
Q4 2019 Feb 14, 2020	SELL	$2.57 - $3.68 $32,035 - $45,871	-12,465 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$3.01 - $4.0 $37,041 - $49,224	-12,306 Reduced 49.68%	12,465 $45,000
Q2 2019 Aug 14, 2019	BUY	$2.79 - $4.31 $69,111 - $106,763	24,771 New	24,771 $83,000
Q4 2018 Feb 14, 2019	SELL	$2.46 - $4.2 $275,384 - $470,169	-111,945 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$3.81 - $5.53 $426,510 - $619,055	111,945 New	111,945 $461,000

15.4M

2.3K

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $32.2M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.